Veterinary Medicines

Nobilis TRT Lyophilisate for suspension

Not authorised
  • Turkey rhinotracheitis virus, strain BUT1#8544, Live
Download as PDF

Product identification

Medicine name:
Nobilis TRT Lyophilisate for suspension
Nobilis TRT
Active substance:
  • Turkey rhinotracheitis virus, strain BUT1#8544, Live
Target species:
  • Turkey
Route of administration:
  • Nebulisation use
  • Intraocular use
  • Nasal use

Product details

Active substance and strength:
  • Turkey rhinotracheitis virus, strain BUT1#8544, Live
    0.40
    tissue culture infective dose 50
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate and solvent for oculonasal suspension
Withdrawal period by route of administration:
  • Nebulisation use
    • Turkey
      • Meat and offal
        0
        day
  • Intraocular use
    • Turkey
      • Meat and offal
        0
        day
  • Nasal use
    • Turkey
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01CD01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Germany
Package description:
  • (ID4): 1 Box with (1 Bottle (Glass) with 5000 Dose and 1 Bottle (-) with 0 millilitre(s)) (5000.0 Dose, 0.0 millilitre(s))
  • (ID3): 1 Box with (1 Bottle (Glass) with 2500 Dose and 1 Bottle (-) with 0 millilitre(s)) (2500.0 Dose, 0.0 millilitre(s))
  • (ID2): 1 Box with (1 Bottle (Glass) with 1000 Dose and 1 Bottle (-) with 0 millilitre(s)) (1000.0 Dose, 0.0 millilitre(s))
  • (ID1): 1 Box with (1 Bottle (Glass) with 500 Dose and 1 Bottle (-) with 0 millilitre(s)) (500.0 Dose, 0.0 millilitre(s))

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Intervet Deutschland GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • INTERVET INTERNATIONAL B.V.
  • Merck Sharp & Dohme Animal Health S.L.
Responsible authority:
  • PEI
Authorisation number:
  • 189a/95
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0205/001

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 11/02/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."